首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with β2-microglobulin intracellular processing and cell surface expression of the HFE protein in COS-7 cells
【2h】

Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with β2-microglobulin intracellular processing and cell surface expression of the HFE protein in COS-7 cells

机译:遗传性血色素沉着:C282Y和H63D突变对与β2-微球蛋白缔合细胞内加工以及COS-7细胞中HFE蛋白的细胞表面表达的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hereditary hemochromatosis (HH) is the most common autosomal recessive disorder known in humans. A candidate gene for HH called HFE has recently been cloned that encodes a novel member of the major histocompatibility complex class I family. Most HH patients are homozygous for a Cys-282→Tyr (C282Y) mutation in HFE gene, which has been shown to disrupt interaction with β2-microglobulin; a second mutation, His-63→Asp (H63D), is enriched in HH patients who are heterozygous for C282Y mutation. The aims of this study were to determine the effects of the C282Y and H63D mutations on the cellular trafficking and degradation of the HFE protein in transfected COS-7 cells. The results indicate that, while the wild-type and H63D HFE proteins associate with β2-microglobulin and are expressed on the cell surface of COS-7 cells, these capabilities are lost by the C282Y HFE protein. We present biochemical and immunofluorescence data that indicate that the C282Y mutant protein: (i) is retained in the endoplasmic reticulum and middle Golgi compartment, (ii) fails to undergo late Golgi processing, and (iii) is subject to accelerated degradation. The block in intracellular transport, accelerated turnover, and failure of the C282Y protein to be presented normally on the cell surface provide a possible basis for impaired function of this mutant protein in HH.
机译:遗传性血色素沉着病(HH)是人类已知的最常见的常染色体隐性遗传疾病。最近已克隆出一种名为HFE的HH候选基因,该基因编码主要的组织相容性复合体I类家族的新成员。大多数HH患者在HFE基因中的Cys-282→Tyr(C282Y)突变是纯合的,已证明可破坏与β2-微球蛋白的相互作用。第二个突变为His-63→Asp(H63D),富含C282Y突变的HH患者。这项研究的目的是确定C282Y和H63D突变对转染的COS-7细胞中HFE蛋白的细胞运输和降解的影响。结果表明,尽管野生型和H63D HFE蛋白与β2-微球蛋白结合并在COS-7细胞的细胞表面表达,但这些能力却被C282Y HFE蛋白丧失了。我们目前的生化和免疫荧光数据表明C282Y突变蛋白:(i)保留在内质网和中高尔基体区室中,(ii)无法经历高尔基体后期加工,并且(iii)加速降解。细胞内运输的阻滞,加速的转换以及C282Y蛋白无法正常显示在细胞表面上,为这种突变蛋白在HH中功能受损提供了可能的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号